tiprankstipranks
Advertisement
Advertisement

QNRX Stock Latest News

Quoin Pharmaceuticals receives notice of allowance for QRX003 patent
The FlyQuoin Pharmaceuticals receives notice of allowance for QRX003 patent
5d ago
QNRX
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
PremiumRatings
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
10d ago
QNRX
Quoin Advances QYLEKI Toward First Netherton Therapy
PremiumCompany Announcements
Quoin Advances QYLEKI Toward First Netherton Therapy
12d ago
8K
QNRX
Quoin Pharmaceuticals announces conditional FDA approval for Qyleki brand name
PremiumThe Fly
Quoin Pharmaceuticals announces conditional FDA approval for Qyleki brand name
12d ago
QNRX
Quoin Pharmaceuticals completes establishment of subsidiary in Japan
PremiumThe Fly
Quoin Pharmaceuticals completes establishment of subsidiary in Japan
17d ago
QNRX
Quoin reports positive pediatric data in Netherton Syndrome program
PremiumThe FlyQuoin reports positive pediatric data in Netherton Syndrome program
19d ago
QNRX
Quoin Pharmaceuticals initiated with a Buy at ThinkEquity
Premium
The Fly
Quoin Pharmaceuticals initiated with a Buy at ThinkEquity
20d ago
QNRX
Quoin Wins Japan Orphan Drug Status for QRX003
Premium
Company Announcements
Quoin Wins Japan Orphan Drug Status for QRX003
1M ago
8K
QNRX
Quoin Pharmaceuticals granted Orphan Drug Designation for QRX003 in Japan
PremiumThe Fly
Quoin Pharmaceuticals granted Orphan Drug Designation for QRX003 in Japan
1M ago
QNRX
Quoin Pharmaceuticals submits QRX003 IND application to FDA
PremiumThe Fly
Quoin Pharmaceuticals submits QRX003 IND application to FDA
1M ago
QNRX
Quoin Pharmaceuticals initiated with a Buy at Lucid Capital
PremiumThe Fly
Quoin Pharmaceuticals initiated with a Buy at Lucid Capital
2M ago
QNRX
Quoin Pharmaceuticals provides regulatory update on QRX009 topical rapamycin
PremiumThe Fly
Quoin Pharmaceuticals provides regulatory update on QRX009 topical rapamycin
2M ago
QNRX
Quoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch
PremiumCompany AnnouncementsQuoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch
3M ago
QNRX
Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays
Premium
Company Announcements
Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays
3M ago
QNRX
Quoin Pharmaceuticals price target raised to $35 from $25 at Alliance Global
Premium
The Fly
Quoin Pharmaceuticals price target raised to $35 from $25 at Alliance Global
3M ago
QNRX
Quoin Pharmaceuticals Ltd – ADR trading resumes
PremiumThe Fly
Quoin Pharmaceuticals Ltd – ADR trading resumes
3M ago
QNRX
Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause
PremiumThe Fly
Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause
3M ago
QNRX
Quoin Pharmaceuticals provides update following QRX003 Type C meeting with FDA
PremiumThe Fly
Quoin Pharmaceuticals provides update following QRX003 Type C meeting with FDA
3M ago
QNRX
Quoin Wins FDA Fast Track for QRX003 in Netherton
PremiumCompany Announcements
Quoin Wins FDA Fast Track for QRX003 in Netherton
4M ago
8K
QNRX
Quoin Pharmaceuticals receives U.S. Fast Track Designation to QRX003
PremiumThe FlyQuoin Pharmaceuticals receives U.S. Fast Track Designation to QRX003
4M ago
QNRX
QNRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
QNRX Earnings this Week: How Will it Perform?
4M ago
QNRX
Quoin Pharmaceuticals highlights continued growth of NETHERTON NOW program
Premium
The Fly
Quoin Pharmaceuticals highlights continued growth of NETHERTON NOW program
4M ago
QNRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >